Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00139295
Other study ID # AVS00103
Secondary ID
Status Completed
Phase Phase 3
First received August 29, 2005
Last updated February 4, 2014
Start date October 2004
Est. completion date September 2007

Study information

Verified date February 2014
Source Sanofi
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationCanada: Health CanadaFrance: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study type Interventional

Clinical Trial Summary

This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date September 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 40 Years and older
Eligibility Inclusion Criteria:

- Diagnosed with OA of the knee

- Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications

Exclusion Criteria:

- Prior or concomitant treatments that would impede measurement of safety and efficacy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Hylastan


Locations

Country Name City State
Canada Sir William Osler Health Institute Hamilton Ontario
France Clinique du Sport Merignac
France Centre Hospitalier Lyon-Sud, Service de Rhumatologie Pierre Benite Cedex
France CHU Hôpital Trousseau Service de Rhumatologie Tours
Germany St-Elisabeth Klinik, Orthopädisch Gemeinschaftspraxis Heidelberg
Germany Orthopaedische Gemeinschaftspraxis Weyhe-Kirchweyhe
United Kingdom Whipps Cross University Hospital NHS Trust, Arthritis Assessment, Physiotherapy Department Leytonstone London
United Kingdom Maidstone General Hospital & Tunbridge Wells NHS Trust Maidstone Kent
United Kingdom Southampton General Hospital, MRC Environmental Epidemiology Unit Southampton Hampshire
United States Capstone Clinical Trials, Inc Birmingham Alabama
United States Midwest Orthopedics at Rush University Medical Center Chicago Illinois
United States Northwestern Center for Clinical Research Chicago Illinois
United States Orthopaedic Specialties of Tampa Bay Clearwater Florida
United States Coastal Orthopedic Associates Conway South Carolina
United States Arthritis & Osteoporosis Center of Maryland Frederick Maryland
United States Orthopedic Center for Joint Replacement and Sports Grants Pass Oregon
United States Bluegrass Orthopaedics/Bluegrass Musculoskeletal Research Lexington Kentucky
United States Hope Research Institute, LLC Phoenix Arizona
United States Rockford Health Physicians Rockford Illinois
United States Unlimited Research San Antonio Texas
United States Arthritis Northwest Seattle Washington
United States Orthopedic Specialists of Louisiana Shreveport Louisiana
United States Tucson Orthopedic Institute, PC Tucson Arizona
United States Clinical Pharmacology Study Group Worcester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Genzyme, a Sanofi Company

Countries where clinical trial is conducted

United States,  Canada,  France,  Germany,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain relief
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A
Completed NCT03037489 - A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients Phase 2
Completed NCT02905747 - The Effect of Medical Exercise Therapy on Pain, Function and Physical Activity in Patients With Knee Osteoarthritis N/A